IVF/ICSI: Optimizing Recombinant FSH Dosing

We are studying the best dose of recombinant FSH for patients undergoing IVF/ICSI to improve hormone levels and pregnancy outcomes. This research may help enhance fertility treatment success.

1-2 yearsMonitoring phase (IV)No PlaceboInvestigational MedicinesInjectionEndocrinologyGynecology and Obstetrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Puregon
Puregon is a fertility medicine that helps stimulate the ovaries to produce eggs for assisted reproductive treatments like IVF.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Corifollitropin Alfa
Corifollitropin alfa is a long-acting fertility hormone used to stimulate ovarian follicle growth during assisted reproductive treatments.
Follitropin Beta
Follitropin beta is a hormone substance used to stimulate the ovaries to produce eggs during fertility treatments.
Lutropin Alfa
Lutropin alfa is a lab-made luteinizing hormone that helps trigger ovulation and support fertility treatments.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Elonva

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Brussel
Brussels IVF
Ganshoren, Belgium
Algemeen Ziekenhuis Jan Palfijn Gent
Fertiliteitscentrum Jan Palfijn AZ Gent
Gent, Belgium
Hopital Erasme
Clinique de fertilité
Negenmanneke, Belgium
Sponsor: UZ Brussel
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.